Article
CDK19 is a Regulator of Triple-Negative Breast Cancer Growth
2018-05-10
Abstract excerpt
Triple-negative breast cancer (TNBC) is a poor prognosis disease with no clinically approved targeted therapies. Here, using in vitro and in vivo RNA interference (RNAi) screens in TNBC patient-derived xenografts (PDX), we identify cyclin dependent kinase 19 (CDK19) as a potential therapeutic target. Using in vitro and in vivo TNBC PDX models, we validated the inhibitory effect of CDK19 knockdown on tumor ini...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5def8b59-8f5a-53f2-9492-5c5cc7d49844
- DOI
- 10.1101/317776
